These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 9620916

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis.
    Rodgers HC, Knox AJ.
    Eur Respir J; 1999 Sep; 14(3):693-6. PubMed ID: 10543294
    [Abstract] [Full Text] [Related]

  • 3. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis.
    Hofmann T, Senier I, Bittner P, Hüls G, Schwandt HJ, Lindemann H.
    J Aerosol Med; 1997 Sep; 10(2):147-58. PubMed ID: 10168532
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    Hirsh AJ, Sabater JR, Zamurs A, Smith RT, Paradiso AM, Hopkins S, Abraham WM, Boucher RC.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):929-38. PubMed ID: 15273255
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
    Middleton PG, House HH.
    Pediatr Pulmonol; 2010 Aug; 45(8):789-95. PubMed ID: 20597077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Status of determining the transepithelial potential difference (PD) of the respiratory epithelium in the diagnosis of mucoviscidosis].
    Unal-Maelger OH, Urbanek R.
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):76-80. PubMed ID: 2452977
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sodium channel but neither Na(+)-H+ nor Na-glucose symport inhibitors slow neonatal lung water clearance.
    O'Brodovich H, Hannam V, Rafii B.
    Am J Respir Cell Mol Biol; 1991 Oct; 5(4):377-84. PubMed ID: 1654956
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR, Church NL, Waltner WE, Yankaskas JR, Gilligan P, King M, Edwards LJ, Helms RW, Boucher RC.
    N Engl J Med; 1990 Apr 26; 322(17):1189-94. PubMed ID: 2157983
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.